Isracann Receives Foreign Owners License and Updates Israeli Cannabis Operations

License paves way for market penetration and growth opportunities     VANCOUVER, BC, — (April 21, 2021) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce it has been granted a Foreign...

Isracann Applauds Expanded Cannabis Accessibility

Broad legalization trending as United Nations, America & Israel signal positive change VANCOUVER, BC, — (March 18, 2021) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is extremely pleased by recent reports and trend data...

Isracann Signs Cannabis Importation LOI with Major Israeli Manufacturer

Canadian Export Product Aim to Help Reduce Shortages in Medical Supply Chain VANCOUVER, BC, — (February 3, 2021) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce it has entered a non-binding...

Isracann Prepares for Recreational Cannabis Opportunity in Israel

Dramatic Consumer Growth Predicted When Legalization Occurs VANCOUVER, BC, — (GLOBE NEWSWIRE – February 25, 2021) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to report on the prevalence of media reports and...

Isracann Completes Phase One Construction at Cannabis Facility in Israel

Hefer Valley farm ready for February inspection and approval to plant   VANCOUVER, BC, — (GLOBE NEWSWIRE – February 16, 2021) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to announce its flagship...

Isracann Prepares to Import Canadian Cannabis into Israel and Europe

Regional Demand Drives Strategic Opportunity VANCOUVER, BC, — ( February 2 2021) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce that the Company has determined to advance foreign importation of Cannabis...

Isracann Well Positioned for Israel’s Cannabis Sector Growth in 2021

Activities in 2020 laid groundwork towards accelerated results VANCOUVER, BC, — ( January 19, 2021) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to provide a year end summary of activities and outlook...

Isracann Announces Launch of Early Warrant Exercise Incentive Program and Repricing

VANCOUVER, British Columbia, Jan. 11, 2021 — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer announces it has implemented a warrant exercise incentive program designed to encourage exercise of up to 20,574,216 of its outstanding share...

Isracann Welcomes International Cannabis Exports in Israel

Legal Exports Poised to Drive Domestic Industry Growth VANCOUVER, BC, — (GLOBE NEWSWIRE – October 14, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to announce that the government of Israel has...

Isracann Updates Cannabis Farm Developments and Advises Processing Facility Expansion Underway

Israeli team committed to aggressive timeline VANCOUVER, BC, — (GLOBE NEWSWIRE – September 1, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer today provides a corporate review and update of its activities in Israel....